Zomedica (ZOMDF) Research & Development (2017 - 2026)
Zomedica (ZOMDF) recorded Research & Development of $1.07 million in Q2 2026, down 43.3% from $1.89 million a year earlier and down 7.3% from the prior quarter.
Zomedica (ZOMDF) Research & Development (2017 - 2026) Analysis & Trends
On a TTM basis, Zomedica's Research & Development came in at $5.65 million as of Jun 30, 2026, down 26.9% year-over-year; for FY2025, it came in at $7.17 million, down 1.4% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $7.27 million in FY2024 (+26.5%), $5.74 million in FY2023 (+122.8%), $2.58 million in FY2022 (+54.1%) and $1.67 million in FY2021 (-79.2%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q3 2023.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with growth averaging 0.5% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 347.2% in Q4 2023, against a decline of 89.3% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.15 million (Q1 2026), $1.64 million (Q4 2025) and $1.78 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Zomedica | 78.40 Mn | -119.63 Mn | 6.04 Mn | 1.07 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.78 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 859,000.00 |
| Mar 31, 2023 | 918,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 319,000.00 |
| Mar 31, 2022 | 351,000.00 |
| Dec 31, 2021 | 665,000.00 |
| Sep 30, 2021 | 289,000.00 |
Zomedica Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();